Company / Operating Cash Flow
Avantor Operating Cash Flow History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$623.8M
FY2025
5-year range
$623.8M / $953.6M
FY2021-FY2025
Trend
-25.8%
vs FY2024
Sector context
#47 of 164
Health Care
What the data says
At $624M, Avantor's operating cash flow ranks #47 of 164 in the Health Care sector. Operating Cash Flow has declined for 4 consecutive years, from $954M in FY2021 to $624M in FY2025.
Based on SEC 10-K filings.
$624M in FY2025 with a 5-year CAGR of -7.7%.
Declined from $870M to $624M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -12.5%
- 5-Year CAGR
- -7.7%
- 10-Year CAGR
- -
Sector benchmark
#47 of 164 in Health CareTop 29% of 164This company $623.8M Sector average $1.0B
▼
-40.2% below sector average
Key checks
Key Insights
- Avantor's operating cash flow has declined for 4 consecutive years.
- 5-year CAGR of -7.7%, indicating a declining trend.
- In FY2025, operating cash flow decreased 25.8% year-over-year.
- Ranks #47 out of 164 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $623.8M | -25.8% |
| FY2024 | $840.8M | -3.4% |
| FY2023 | $870.0M | -6.4% |
| FY2022 | $929.8M | -2.5% |
| FY2021 | $953.6M | +2.6% |
| FY2020 | $929.8M | +655.1% |
| FY2019 | -$167.5M | -183.5% |
| FY2018 | $200.5M | +219.7% |
| FY2017 | -$167.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026